A Clinical Study With MT-102 in Subjects With Cancer Cachexia

ABSTRACT: A phase II clinical study to evaluate MT-102 administered over a sixteen week period in subjects with cachexia related to non-small cell lung cancer and colorectal cancer

DISEASE(S): Cancer Cachexia,Cachexia,Wasting Syndrome,Cancer

PROVIDER: 2097861 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR